A NEW DIMENSION IN POINT-OF-CARE BLOOD TESTING
PRODUCTS-THE EPINEX SIMPLYSURE PT-INR BLOOD COAGULATION TEST
The Epinex SimplySure PT-INR Test
The SimplySure PT-INR (Prothrombin Time-International Normalized Ratio) Test for whole blood coagulation leverages a unique, patented technology that provides a visual quantitative reading directly on the test strip without the need of an expensive external test instrument.
Existing tests for PT-INR are based on electrochemical detection using chemical sensors and digital detection by means of an expensive external reader device. The SimplySure test is a microfluidic device that causes the blood sample move across a chemical laden strip by a certain distance that equates to what the PTINR test measures.
Features of the Epinex SimplySure PT-INR Test
-
The first quantitative, “un-plugged” whole blood coagulation test for PT/INR!
-
No capital expenditure, No instrument needed
-
Uses a few drops of whole blood
-
Point-of-Care convenience – Healthcare providers can test patients or have patients test themselves at home.
-
Fast Results – typically in less than three minutes.
-
Easy to use – runs like a glucose test and reads like a thermometer.
-
Compact & Disposable device
-
Patent protected (US patent 6,759,009, issued July 2004)
Epinex SimplySure PT-INR ADVANTAGE OVER THE COMPETTION
-
SimplySure PT-INR does not require complex and costly instrumentation for testing.
-
All competition requires upfront instrument/device cost >$900.
-
Simplicity and cost effectiveness of SimplySure PT-INR enables easy physician office or self-testing without need for additional infrastructure or patient assistance.
-
Disposable test design facilitates INR monitoring at any time any place.
* This product is under development and is intended for information and evaluation purposes only. It is NOT APPROVED by the USFDA.